Q3-2025 Portfolio Highlights Subsequent to the nine months ended September 30, 2025, the Company announced that it had entered into a definitive option agreement with a wholly owned subsidiary of BHP ...
Ubiquitin pathway blockade reveals endogenous ADP-ribosylation marking PARP7 and AHR for degradation
Degradation mechanisms of transcriptionally active aryl hydrocarbon receptor (AHR) are unclear. This work reveals that PARP7 ...
A Supreme Court ruling eroding FCC deference, state laws imposing tighter time limits and penalties, and UDAP statutes ...
Poised to be able to Supply Up to 50% of U.S. Natural Graphite Demand with Federal Backing Under EXIM’s “Make More in America” Initiative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback